Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity
- 23 June 2004
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 200 (2) , 159-168
- https://doi.org/10.1016/j.taap.2004.04.005
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Carvedilol Protects against Doxorubicin-Induced Mitochondrial CardiomyopathyToxicology and Applied Pharmacology, 2002
- Interference with Calcium-Dependent Mitochondrial Bioenergetics in Cardiac Myocytes Isolated from Doxorubicin-Treated RatsToxicology and Applied Pharmacology, 2001
- Antioxidant Agent Nimesulid and β-Blocker Metoprolol Do Not Exert Protective Effects against Rat Mitochondrial DNA Alterations in Adriamycin-Induced CardiotoxicityBiochemical and Biophysical Research Communications, 1999
- Preferential oxidation of cardiac mitochondrial DNA following acute intoxication with doxorubicinBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1997
- Dose-dependent Increase in Sensitivity to Calcium-induced Mitochondrial Dysfunction and Cardiomyocyte Cell Injury by DoxorubicinJournal of Molecular and Cellular Cardiology, 1996
- Disruption of Mitochondrial Calcium Homeostasis Following Chronic Doxorubicin AdministrationToxicology and Applied Pharmacology, 1994
- CarvedilolDrugs, 1993
- Ultrastructural alterations of the myocardium induced by doxorubicinVirchows Archiv B Cell Pathology Including Molecular Pathology, 1991
- Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady stateThe Journal of Membrane Biology, 1979
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976